These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20147728)

  • 1. FDA drug information that never reaches clinicians.
    Hohneker J; Ericson S; Gruia G
    N Engl J Med; 2010 Feb; 362(6):561; author reply 563. PubMed ID: 20147728
    [No Abstract]   [Full Text] [Related]  

  • 2. New bisphosphonic acid approved by FDA.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1792. PubMed ID: 11596691
    [No Abstract]   [Full Text] [Related]  

  • 3. Zoledronic acid. A bisphosphonate for hypercalcemia of malignancy and osteolytic metastases.
    Massaro AM
    Cancer Pract; 2002; 10(4):219-21. PubMed ID: 12100107
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid.
    Diel IJ; Bergner R
    Oncologist; 2005 Jan; 10(1):82-3; author reply 84-7. PubMed ID: 15632256
    [No Abstract]   [Full Text] [Related]  

  • 5. "Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
    Lugassy G
    Oncologist; 2005 May; 10(5):309-10; author reply 311-2. PubMed ID: 15851782
    [No Abstract]   [Full Text] [Related]  

  • 6. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA drug information that never reaches clinicians.
    Messerli FH; Bangalore S
    N Engl J Med; 2010 Feb; 362(6):562; author reply 563. PubMed ID: 20175300
    [No Abstract]   [Full Text] [Related]  

  • 8. Consumer groups look to improve adverse event reporting systems.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1804-5. PubMed ID: 16368939
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacist-run zoledronic acid clinic.
    Traina AN; Kane MP; Bakst G; Abelseth JM; Busch RS
    Am J Health Syst Pharm; 2011 Aug; 68(15):1399-403. PubMed ID: 21785027
    [No Abstract]   [Full Text] [Related]  

  • 10. [Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)].
    Ringe JD; Nitschmann S
    Internist (Berl); 2008 Apr; 49(4):502-4. PubMed ID: 18305914
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma.
    Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A
    Ann Oncol; 2009 Feb; 20(2):389-90. PubMed ID: 19153111
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous bisphosphonates and osteonecrosis.
    Greenberg MS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):259-60. PubMed ID: 15356460
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hypocalcaemia after being given intravenous bisphosphonate.
    Peter R; Mishra V; Fraser WD
    BMJ; 2004 Feb; 328(7435):335-6. PubMed ID: 14764499
    [No Abstract]   [Full Text] [Related]  

  • 14. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A
    J Postgrad Med; 2008; 54(3):237. PubMed ID: 18626181
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA grants priority review for ZOMETA.
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):325. PubMed ID: 12113096
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of acquired Fanconi syndrome induced by zoledronic acid.
    Yoshinami T; Yagi T; Sakai D; Sugimoto N; Imamura F
    Intern Med; 2011; 50(9):1075-9. PubMed ID: 21532237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.
    Taggart H; Cheng J; Archbold P
    Osteoporos Int; 2010 Sep; 21(9):1621-2. PubMed ID: 19813042
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteonecrosis of the jaw.
    Sari E; Bulut N; Altundag K
    J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential effect of zoledronate therapy in heavy proteinuria.
    Gokden N; Zangari M; Elici F; Barlogie B; Kumar J
    Clin Nephrol; 2007 Apr; 67(4):263-5. PubMed ID: 17474565
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget's disease.
    Watts MR; Ellims AH; Eccleston DS
    Med J Aust; 2014 Feb; 200(3):150. PubMed ID: 24528425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.